Citigroup’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $152M | Buy |
2,165,414
+685,380
| +46% | +$35.5M | 0.05% | 326 |
|
|
2026
Q1 | $75.2M | Sell |
1,480,034
-456,479
| -24% | -$21.3M | 0.03% | 495 |
|
|
2025
Q4 | $57.1M | Sell |
1,936,513
-145,527
| -7% | -$3.95M | 0.03% | 590 |
|
|
2025
Q3 | $53.8M | Sell |
2,082,040
-361,604
| -15% | -$10.1M | 0.02% | 600 |
|
|
2025
Q2 | $67.4M | Sell |
2,443,644
-65,288
| -3% | -$1.72M | 0.03% | 486 |
|
|
2025
Q1 | $71.1M | Buy |
2,508,932
+817,727
| +48% | +$29M | 0.04% | 443 |
|
|
2024
Q4 | $70.3M | Buy |
1,691,205
+1,099,295
| +186% | +$52.5M | 0.04% | 388 |
|
|
2024
Q3 | $39.6M | Buy |
591,910
+138,378
| +31% | +$12.7M | 0.02% | 632 |
|
|
2024
Q2 | $53.9M | Buy |
453,532
+25,335
| +6% | +$3.21M | 0.03% | 464 |
|
|
2024
Q1 | $45.6M | Sell |
428,197
-74,273
| -15% | -$7.49M | 0.03% | 527 |
|
|
2023
Q4 | $50M | Sell |
502,470
-176,908
| -26% | -$14.9M | 0.04% | 457 |
|
|
2023
Q3 | $70.2M | Buy |
679,378
+86,811
| +15% | +$9.68M | 0.05% | 314 |
|
|
2023
Q2 | $72M | Sell |
592,567
-113,607
| -16% | -$15.2M | 0.05% | 324 |
|
|
2023
Q1 | $108M | Sell |
706,174
-379,989
| -35% | -$62.7M | 0.08% | 208 |
|
|
2022
Q4 | $195M | Buy |
1,086,163
+294,199
| +37% | +$48.1M | 0.16% | 118 |
|
|
2022
Q3 | $93.7M | Sell |
791,964
-141,474
| -15% | -$21.5M | 0.07% | 231 |
|
|
2022
Q2 | $133M | Sell |
933,438
-125,245
| -12% | -$17.9M | 0.1% | 172 |
|
|
2022
Q1 | $182M | Sell |
1,058,683
-42,605
| -4% | -$7.17M | 0.11% | 159 |
|
|
2021
Q4 | $280M | Buy |
1,101,288
+550,315
| +100% | +$161M | 0.15% | 115 |
|
|
2021
Q3 | $212M | Buy |
550,973
+195,392
| +55% | +$72.1M | 0.13% | 139 |
|
|
2021
Q2 | $83.6M | Sell |
355,581
-169,809
| -32% | -$30.3M | 0.05% | 352 |
|
|
2021
Q1 | $68.8M | Buy |
525,390
+71,240
| +16% | +$10.3M | 0.04% | 373 |
|
|
2020
Q4 | $47.4M | Buy |
454,150
+236,851
| +109% | +$24M | 0.03% | 565 |
|
|
2020
Q3 | $15.4M | Sell |
217,299
-127,096
| -37% | -$8.86M | 0.01% | 1067 |
|
|
2020
Q2 | $22.1M | Buy |
344,395
+223,218
| +184% | +$12.2M | 0.02% | 771 |
|
|
2020
Q1 | $3.63M | Sell |
121,177
-133,134
| -52% | -$3.06M | ﹤0.01% | 1939 |
|
|
2019
Q4 | $4.97M | Sell |
254,311
-85,535
| -25% | -$1.52M | ﹤0.01% | 2030 |
|
|
2019
Q3 | $5.41M | Buy |
339,846
+339,805
| +828,793% | +$5.02M | ﹤0.01% | 1875 |
|
|
2019
Q2 | $1K | Sell |
41
-783
| -95% | -$16.8K | ﹤0.01% | 7681 |
|
|
2019
Q1 | $17K | Buy |
+824
| New | +$15.3K | ﹤0.01% | 7034 |
|
Other funds holding MRNA
TP
Citigroup's MRNA Position: Q2 2026 in Review
Citigroup increased its Moderna (MRNA) stake by 46% in Q2 2026, buying an estimated $35.5M and bringing the position to 2,165,414 shares worth $152M. The position accounts for 0.05% of the portfolio, ranked #326.
Citigroup first reported a position in MRNA in Q1 2019 and has held it in 30 quarters since. The position peaked at $280M in Q4 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Citigroup held 2,165,414 shares of Moderna worth $152M as of Q2 2026.
- Citigroup bought 685,380 Moderna shares in Q2 2026, an estimated $35.5M.
- Moderna made up 0.05% of Citigroup's portfolio in Q2 2026, its #326 holding.
- Citigroup first reported a position in Moderna in Q1 2019 and has held it in 30 quarters since.
- Citigroup's Moderna position peaked at $280M in Q4 2021.
- 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.